Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma
Clinical trial NCT03161756 · UNKNOWN
Trial details
- NCT number
- NCT03161756
- Sponsor
- Melanoma and Skin Cancer Trials Limited
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-07
- Primary completion
- 2021-12-31
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.